Clinical Trial Update: Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) [Phase 1]

View source ↗

Summary

Phase 1 study of MK-1697 in advanced solid tumors has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Head and Neck Neoplasms
• Neoplasms

Drugs mentioned

• MK-1697 (MK-1697)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Colorectal Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2021-02-12